TipRanks
Enlivex Therapeutics Ltd (DE:1BT)
FRANKFURT:1BT
Germany Market
1BT
Enlivex
RESEARCH TOOLSreports

Enlivex (1BT) Stock News & Sentiment

0 Followers
Enlivex Calls October 14 Extraordinary Meeting to Approve 1-for-16 Reverse Share Split
Premium
Company Announcements
Enlivex Calls October 14 Extraordinary Meeting to Approve 1-for-16 Reverse Share Split
16d ago
6K
ENLV
Enlivex Posts Massive H1 2026 Profit on Surging Digital Asset Holdings
Premium
Company Announcements
Enlivex Posts Massive H1 2026 Profit on Surging Digital Asset Holdings
20d ago
6K
ENLV
Enlivex Drops RAIN-Token Financing Deal, Halts Planned Private Placement
Premium
Company Announcements
Enlivex Drops RAIN-Token Financing Deal, Halts Planned Private Placement
23d ago
6K
ENLV
Enlivex Restructures $19.2 Million Convertible Note With Lind, Easing Default Risk
Premium
Company Announcements
Enlivex Restructures $19.2 Million Convertible Note With Lind, Easing Default Risk
2M ago
6K
ENLV
Enlivex Highlights 622% Surge in Rain Protocol Trading Volume to $860 Million
Premium
Company Announcements
Enlivex Highlights 622% Surge in Rain Protocol Trading Volume to $860 Million
3M ago
6K
ENLV
Enlivex to Brief Investors on Private Placement, Rain Treasury Strategy and Allocetra RMAT Milestone
Premium
Company Announcements
Enlivex to Brief Investors on Private Placement, Rain Treasury Strategy and Allocetra RMAT Milestone
3M ago
6K
ENLV
Enlivex Strikes $400 Million Private Placement Tied to RAIN Token Treasury Strategy
Premium
Company Announcements
Enlivex Strikes $400 Million Private Placement Tied to RAIN Token Treasury Strategy
3M ago
6K
ENLV
More DE:1BT News >

1BT News on the Web

Enlivex Calls October 14 Extraordinary Meeting to Approve 1-for-16 Reverse Share Split
TipRanks News
Neutral
Enlivex Strikes $400 Million Private Placement Tied to RAIN Token Treasury Strategy
TipRanks News
Neutral
Enlivex Reveals $1.1 Billion RAIN Token Treasury and $66.16 NAV Per Share
TipRanks News
Neutral
Enlivex Wins FDA RMAT Status for Allocetra in Age-Related Knee Osteoarthritis
TipRanks News
Neutral
Enlivex's Allocetra Cell Therapy For Knee Osteoarthritis Gets FDA's RMAT Designation; Stock Down
rttnews
Bullish
Enlivex Therapeutics receives RMAT designation for Allocetra from FDA
TipRanks News
Bullish
FDA RMAT Designation Positions Enlivex’s Allocetra as a Potential Breakthrough in Knee Osteoarthritis
Market Chameleon
Neutral
Enlivex Therapeutics trading halted, news pending
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:1BT’s Media Buzz Sentiment?
Currently, no data Available
What is DE:1BT’s weekly average amount of articles?
In an average week, 0.75 articles about DE:1BT are published.
    What is DE:1BT’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    NTRANatera
    RYTMRhythm Pharmaceuticals
    MIRMMirum Pharmaceuticals
    HAEHaemonetics
    HRMYHarmony Biosciences Holdings
    Showing the stocks with the most bullish news sentiment over the past week